Showing results (21-30 of 67) with videos related to
Sort By:
Pageof 7
Pacing and Clinical Electrophysiology : PACE|April 17, 2015
Quality of Life in Young Adult Patients with a Cardiogenetic Condition Receiving an ICD for Primary Prevention of Sudden Cardiac DeathAgnes J Verkerk, Alexa M Vermeer, Ellen M Smets, et al.Journal of Community Genetics|December 14, 2024
Development of a digital risk-prediction tool based on family health history for the general population: legal and ethical implicationsTetske Dijkstra, M Corrette Ploem, Irene M van Langen, et al.European Journal of Human Genetics : EJHG|November 24, 2021
A tailored approach to informing relatives at risk of inherited cardiac conditions: results of a randomised controlled trialLieke M van den Heuvel, Yvonne M Hoedemaekers, Annette F Baas, et al.American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|June 25, 2013
Ebstein anomaly associated with left ventricular noncompaction: an autosomal dominant condition that can be caused by mutations in MYH7Alexa M C Vermeer, Klaartje van Engelen, Alex V Postma, et al.Circulation. Genomic and Precision Medicine|October 20, 2020
Long-Term Follow-Up Study on the Uptake of Genetic Counseling and Predictive DNA Testing in Inherited Cardiac ConditionsLieke M van den Heuvel, Maxiem O van Teijlingen, Wilma van der Roest, et al.European Heart Journal. Cardiovascular Imaging|January 27, 2012
Multiple myocardial crypts on modified long-axis view are a specific finding in pre-hypertrophic HCM mutation carriersWessel P Brouwer, Tjeerd Germans, Maaike C Head, et al.European Journal of Human Genetics : EJHG|May 5, 2019
Informing relatives at risk of inherited cardiac conditions: experiences and attitudes of healthcare professionals and counseleesLieke M van den Heuvel, Mette J Huisinga, Yvonne M Hoedemaekers, et al.Journal of Cellular Biochemistry|January 12, 2012
TGFβ-inducible early gene-1 (TIEG1) mutations in hypertrophic cardiomyopathyJ Martijn Bos, Malayannan Subramaniam, John R Hawse, et al.European Journal of Heart Failure|October 25, 2011
Carriers of the hypertrophic cardiomyopathy MYBPC3 mutation are characterized by reduced myocardial efficiency in the absence of hypertrophy and microvascular dysfunctionStefan A J Timmer, Tjeerd Germans, Wessel P Brouwer, et al.European Journal of Human Genetics : EJHG|May 21, 2026
Towards responsible genome-wide screening: normative and stakeholder considerationsCorrette Ploem, Guido de Wert, Sara Soriano Longarón, et al.Pageof 7